Simvastatin ≥98% (durch TLC)
Lieferant: ENZO LIFE SCIENCES AG
ENZOBMLG2440050EA
183
CHF
ENZOBMLG2440050
ENZOBMLG2440250
Simvastatin ≥98% (durch TLC)
Simvastatin
HMG-CoA reductase inhibitor
HMG-CoA reductase inhibitor. Synthetic analog of Lovastatin (Prod. No. BML-G226). Inhibits the biosynthesis of isoprenoids and prevents small G protein activation. Displays lipid lowering and antihypertensive effects. Displays antiinflammatory, immunomodulatory effects as well as protective effects in experimental traumatic brain injury. Activates Rac1-dependent signalling pathway.
Formel:
C25H38O5 MW: 418,57 g/mol |
MDL Number:
MFCD00072007 CAS-Nummer: 79902-63-9 |
Learn more
About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...